2020-2025 U.K. Nucleic Acid Testing (NAT) Diagnostics Database: Market Shares and Forecasts for 100 Tests-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This database from LeadingMarketResearch.com provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests.
LIST OF TABLES
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
U.K. Molecular Diagnostics Test Volume And Sales By Major Application
U.K. Laboratories Performing DNA Sequencing By Market Segment
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K. Molecular Diagnostics Test Volume By Major Application
U.K. Major Infectious Disease Test Volume by Assay
U.K. Major Infectious Disease Test Volume by Method
U.K. Molecular Diagnostics Market By Major Application
U.K. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.K. Major Infectious Disease Diagnostics Market by Assay
U.K. AIDS Testing Market Estimated Sales by Major Supplier
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
U.K. Molecular Diagnostics Test Volume And Sales By Major Application
U.K. Laboratories Performing DNA Sequencing By Market Segment
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K. Molecular Diagnostics Test Volume By Major Application
U.K. Major Infectious Disease Test Volume by Assay
U.K. Major Infectious Disease Test Volume by Method
U.K. Molecular Diagnostics Market By Major Application
U.K. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.K. Major Infectious Disease Diagnostics Market by Assay
U.K. AIDS Testing Market Estimated Sales by Major Supplier
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
More Publications
Future Horizons in the UK Hematology and Flow Cytometry Market: Supplier Shares and Sales Forecasts for 40 Tests by Market Segment
US$ 4,400.00
August 2012
250 pages
UK HIV/AIDS Testing Market in Hospitals, Blood Banks, Commercial Labs-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 2,300.00
July 2019
251 pages
UK Endocrine Function Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023
US$ 1,850.00
July 2019
269 pages
UK Flow Cytometry Reagent and Instrument Market, 2019-2023: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,900.00
July 2019
146 pages
2017-2021 UK Hepatitis Diagnostic Testing Market
US$ 3,510.00
February 2017
241 pages